ProMIS Neurosciences names Ivana Rubino chief commercial officer

ProMIS Neurosciences appointed Ivana Rubino as chief commercial officer, effective Oct. 5, 2026. Rubino previously served at Biogen as vice president, global head of Alzheimer’s disease and multiple sclerosis medical.